SecSonar.com

YD Bio Limited Ordinary Shares (YDES)

YD Bio Limited Ordinary Shares at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

YD Bio Limited Ordinary Shares (YDES) is a Biotechnology company based in TW with a market capitalization of $223.1M. Revenue grew 16.9% year-over-year and free cash flow was negative at -$8M. This page tracks YDES's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

TW · 4 employees · IPO Aug 29, 2025

Valuation

Valuation & price

$5.17 · as of May 17, 2026 · -77.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$23.11$12.80$2.50Aug 25Jan 26Jun 26Aug 5, 25$12.04Aug 8, 25$11.90Aug 12, 25$12.10Aug 19, 25$12.77Aug 21, 25$9.50Aug 25, 25$11.80Aug 27, 25$12.00Aug 28, 25$5.30Sep 2, 25$13.65Sep 4, 25$14.73Sep 8, 25$15.93Sep 10, 25$16.39Sep 12, 25$23.11Sep 15, 25$17.10Sep 17, 25$18.40Sep 19, 25$19.78Sep 23, 25$21.06Sep 25, 25$14.25Sep 29, 25$18.07Sep 30, 25$19.47Oct 2, 25$19.27Oct 6, 25$18.20Oct 8, 25$17.06Oct 10, 25$17.41Oct 14, 25$18.51Oct 16, 25$18.86Oct 17, 25$20.09Oct 21, 25$18.53Oct 23, 25$17.61Oct 27, 25$17.11Oct 29, 25$13.24Oct 31, 25$11.43Nov 3, 25$11.33Nov 5, 25$10.54Nov 7, 25$8.99Nov 11, 25$8.84Nov 13, 25$10.12Nov 17, 25$10.73Nov 18, 25$9.77Nov 20, 25$8.36Nov 24, 25$8.83Nov 26, 25$10.52Dec 1, 25$12.50Dec 3, 25$12.96Dec 5, 25$13.91Dec 8, 25$15.42Dec 10, 25$12.64Dec 12, 25$12.40Dec 16, 25$12.62Dec 18, 25$11.34Dec 22, 25$12.13Dec 23, 25$12.09Dec 26, 25$12.24Dec 30, 25$11.97Jan 2, 26$12.00Jan 6, 26$11.66Jan 8, 26$12.33Jan 9, 26$12.34Jan 13, 26$11.82Jan 15, 26$11.42Jan 20, 26$11.95Jan 22, 26$12.30Jan 26, 26$12.03Jan 28, 26$12.24Jan 29, 26$11.03Feb 2, 26$11.47Feb 4, 26$11.13Feb 6, 26$11.28Feb 10, 26$11.20Feb 12, 26$9.81Feb 13, 26$9.84Feb 18, 26$8.52Feb 20, 26$8.02Feb 24, 26$8.06Feb 26, 26$9.03Mar 2, 26$8.70Mar 3, 26$8.47Mar 5, 26$8.38Mar 9, 26$7.90Mar 11, 26$7.71Mar 13, 26$7.30Mar 17, 26$7.11Mar 19, 26$5.42Mar 20, 26$5.46Mar 24, 26$7.73Mar 26, 26$7.73Mar 30, 26$8.10Apr 1, 26$7.29Apr 6, 26$7.12Apr 7, 26$6.98Apr 9, 26$5.78Apr 13, 26$5.74Apr 15, 26$5.44Apr 17, 26$5.44Apr 21, 26$5.16Apr 22, 26$5.32Apr 24, 26$5.46Apr 28, 26$5.20Apr 30, 26$5.10May 4, 26$5.02May 6, 26$5.19May 8, 26$5.31May 11, 26$5.31May 13, 26$5.20May 15, 26$5.18May 19, 26$4.99May 21, 26$4.52May 26, 26$4.31May 27, 26$3.94May 29, 26$3.22Jun 2, 26$3.19Jun 4, 26$3.15Jun 8, 26$2.97Jun 10, 26$3.11Jun 11, 26$3.25Jun 15, 26$3.39Jun 17, 26$2.52Jun 22, 26$2.79Jun 24, 26$2.63Jun 29, 26$2.50
$2.3552-week range$23.11
Loading valuation history…

Fundamentals

Key fundamentals

$223.1M

Market cap

16.9%

Revenue growth (YoY)

-7.1%

Gross margin

-$8M

Free cash flow (USD)

-$6M

Net debt

Net cash position

1509.3%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2020 → 2025

FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$350.1KFY 2024$510.4KFY 2025$596.8K
$0$596.8K

Free cash flow by year

2020 → 2025

FY 2020$-253.6KFY 2021$-688.4KFY 2022$-3.0MFY 2023$-55.9KFY 2024$-4.7MFY 2025$-8.0M
-$253.6K-$8M

Gross margin by year

2023 → 2025

FY 202343.8%FY 202430.4%FY 2025-7.1%
43.8%-7.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed May 1, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Annual reportAnnual Report FiledMay 1, 2026Filing
  • Annual report20-F FiledApr 30, 2026Filing

Questions

Frequently asked questions

What is YD Bio Limited Ordinary Shares's market cap?

YD Bio Limited Ordinary Shares (YDES) has a market capitalization of $223.1M.

What is YDES's P/E ratio?

A meaningful P/E ratio is not available for YDES — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying YDES stock?

SEC Form 4 filings show no open-market insider buys at YD Bio Limited Ordinary Shares in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

HUMA

Humacyte, Inc.

$222.6M

SLGL

Sol-Gel Technologies Ltd.

$225.3M

ARCT

Arcturus Therapeutics Holdings Inc.

$225.4M

PRLD

Prelude Therapeutics Incorporated

$218.6M

WHWK

Whitehawk Therapeutics Inc

$232.4M

NBP

NovaBridge Biosciences

$213.2M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.